Literature DB >> 2205950

Proteolytic and immunologic comparison of human and bovine von Willebrand factor.

M R Bakhshi1, E P Kirby.   

Abstract

The structures of bovine and human vWF were compared by proteolysis with Staphylococcus aureus V8 protease and rattlesnake venom Protease I. Fragments were analyzed for chain composition, heparin binding, collagen binding, platelet agglutinating activity and recognition by a panel of monoclonal antibodies which reacted with both bovine and human vWF. Similar large fragments from the C-terminal domain of vWF were seen in each case. The N-terminal domain resulting from cleavage of bovine vWF was much smaller than that seen upon digestion of human vWF with V8 protease. Protease I destroyed the heparin binding domain in human vWF. Bovine vWF was much less sensitive to proteolysis than was human vWF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205950

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.

Authors:  T Kawasaki; Y Taniuchi; N Hisamichi; Y Fujimura; M Suzuki; K Titani; Y Sakai; S Kaku; N Satoh; T Takenaka
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

2.  The role of the 5'-flanking region in the cell-specific transcription of the human von Willebrand factor gene.

Authors:  V Ferreira; Z Assouline; J L Schwachtgen; B R Bahnak; D Meyer; D Kerbiriou-Nabias
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

3.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.